 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1b9e
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biochemical function
|
hormone activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Acta Crystallogr D Biol Crystallogr
55:1524-1532
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of an insulin dimer in an orthorhombic crystal: the structure analysis of a human insulin mutant (B9 Ser-->Glu).
|
|
Z.P.Yao,
Z.H.Zeng,
H.M.Li,
Y.Zhang,
Y.M.Feng,
D.C.Wang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure of human insulin mutant B9 (Ser-->Glu) was determined by an X-ray
crystallographic method at 2.5 A resolution with an R factor of 0.165 under
non-crystallographic restraints. The crystals were grown at low pH (<3.8) and
belong to the orthorhombic P2(1)2(1)2(1) space group with unit-cell dimensions a
= 44.54, b = 46.40, c = 51.85 A and one dimer per asymmetric unit without
further aggregation. The structure in this crystal form can be regarded as a
model for a discrete insulin dimer and displays the following features compared
with the structure of 2Zn insulin. (i) The overall dimer is expanded and more
symmetric. The two A chains are about 2 A more distant from each other, while
the two B chains are about 0.8 A further apart. Both monomers are more similar
to molecule 1 than molecule 2 of the 2Zn insulin dimer. (ii) The dimer structure
is stabilized by protonation and neutralization of the carboxyl groups at lower
pH and, in addition, by formation of a hydrogen-bond network among the side
chains of residues GluB9, HisB13 and HisB10 on the dimer-forming surface of both
monomers, resulting from a structural rearrangement. (iii) The B-chain
amino-terminal segment is in an open state (O state), i.e. a state different
from the well known R and T states found in the insulin hexamer. In the O state,
the B-chain N-terminal segment is in an extended conformation and is detached
from the rest of the molecule. This conformational state has also been observed
in the monomeric crystal structure of despentapeptide (B26-B30) and
desheptapeptide (B24-B30) insulin, as well as in the solution structure of an
engineered insulin monomer. It suggests that the O state may be the
characteristic conformation of insulin in lower aggregation forms and may be
relevant to the formation of insulin fibrils. In addition, based on the
crystallization process, the smallest possible building blocks of insulin
crystal are also discussed.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 7.
Figure 7 Hydrogen-bond network among side chains of B9, B10 and
B13 from both monomers at the dimer-forming surface. Distances
are in Å.
|
 |
Figure 8.
Figure 8 Conformational comparison of B-chain N-terminal
residues, showing the O state (a) in the crystal and (b) in
solution. (a) Overlapped structures of B9E HI (red), DPI (blue),
DHPI (green). (b) The 25 NMR structures (green) of engineered
(B1, B10, B16, B27)Glu, des B30-insulin overlapped on B9E HI
(red). The coordinates of DPI, DHPI and (B1, B10, B16, B27)Glu,
des B30-insulin are taken from the Protein Data Bank, with codes
1pid, 1dei and 1hui, respectively.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the IUCr:
Acta Crystallogr D Biol Crystallogr
(1999,
55,
1524-1532)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.C.Welinder,
J.Zhang,
D.B.Steensgaard,
and
J.Ulstrup
(2010).
Adsorption of human insulin on single-crystal gold surfaces investigated by in situ scanning tunnelling microscopy and electrochemistry.
|
| |
Phys Chem Chem Phys, 12,
9999.
|
 |
|
|
|
|
 |
A.Ahmad,
V.N.Uversky,
D.Hong,
and
A.L.Fink
(2005).
Early events in the fibrillation of monomeric insulin.
|
| |
J Biol Chem, 280,
42669-42675.
|
 |
|
|
|
|
 |
V.Zoete,
M.Meuwly,
and
M.Karplus
(2005).
Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition.
|
| |
Proteins, 61,
79-93.
|
 |
|
|
|
|
 |
A.Ahmad,
I.S.Millett,
S.Doniach,
V.N.Uversky,
and
A.L.Fink
(2004).
Stimulation of insulin fibrillation by urea-induced intermediates.
|
| |
J Biol Chem, 279,
14999-15013.
|
 |
|
|
|
|
 |
B.Y.Zhang,
M.Liu,
and
P.Arvan
(2003).
Behavior in the eukaryotic secretory pathway of insulin-containing fusion proteins and single-chain insulins bearing various B-chain mutations.
|
| |
J Biol Chem, 278,
3687-3693.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
| |